Premier Perspectives The blog for insider insights in clinical development Consulting The New Drug-Drug Interaction Guidance, ICH M12: How to Accelerate Your Drug Development Program By Madelyn Huang July 8, 2024 Featured Posts Clinical ResearchPhase 1 - Phase 4 Early Cell Therapy Development: Navigating the Journey to First-In-Human Studies By Madelyn Huang June 14, 2024 Consulting 3 Characteristics of a Successful Cell and Gene Therapy Nonclinical Program By Madelyn Huang April 24, 2024 1 × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today